SUN PHARMACEUTICALS
INDUSTRIES LTD.
Maanhvi Ralhan
06.07.2019
ESTABLISHMENT & GROWTH
1983
Sun Pharma established by Mr. Dilip Shanghvi with
five psychiatry products and a two person
marketing team
1994
Sun Pharma launches IPO
1996
Sun Pharma expands sales network across 24
countries
2007
Sun Pharma demerges Sun Pharma Advanced
Research Company (SPARC), into a separate entity
becoming the first pure research company to be
listed on Indian stock exchanges
2013
Ranbaxy acquisition catapults Sun Pharma to
world’s 5th largest specialty generic
ACQUISITIONS & ALLIANCES
1996
Sun Pharma acquires API plant from Knoll Pharma at Ahmednagar, Maharashtra, India
1997
Sun Pharma purchases equity stakes in TDPL and MJ Pharma
Sun Pharma’s first international acquisition of Caraco Pharmaceutical Laboratories, USA
1999
Sun Pharma acquires Milmet Labs and Gujarat Lyka Organics, India
2000
Sun Pharma acquires Pradeep Drug Company, India
2004
Sun Pharma acquires Phlox Pharma (India) and niche brands from Women’s First
Healthcare (US)
2005
Sun Pharma completes buyout of manufacturing
unit in Bryan, Ohio, US
Sun Pharma acquires ICN’s business in Hungary
from Valeant Pharma
Sun Pharma acquires intellectual property and
assets of Able Labs from US District Bankruptcy
court in New Jersey
2008
Sun Pharma acquires Chattem Chemicals Inc, US
2010
Sun Pharma acquires controlling stake in Israel-
based Taro Pharmaceuticals, USA to effectively
double company's US business
2012
Sun Pharma completes two more acquisitions in
USA; Dusa Pharmaceuticals and the generic
business of URL Pharmaceuticals
2014
Sun Pharma acquires Ranbaxy in a US$ 4 billion
landmark transaction to create world’s fifth largest
specialty generic pharma company
Sun Pharma acquires Pharmalucence in USA
2015
Sun Pharma acquires GSK’s Opiates business in
Australia
Sun Pharma acquires InSite Vision Inc. to
strengthen branded ophthalmic portfolio in USA
2016
Sun Pharma acquires 14 brands from Novartis in
Japan
Sun Pharma acquires Ocular Technologies, Sarl to
strengthen branded ophthalmic portfolio
Sun Pharma acquires branded oncology product
Odomzo® (sonidegib) from Novartis for global
markets
Sun Pharma acquires Biosintez to enhance
presence in Russian market
rs Sun Pharma has had numerous Acquisitions and Joint Ventures with the companies
SUNOLOGY
Sunology - a combination of two words, Sun & Ideology is at the core of Sun.
Humility, Integrity, Passion & Innovation together form Sunology.
It is a way of life at Sun.
Humility
•
Under promise and over deliver
•
Let your work speak for you
•
Always put ‘we’ before ‘me’
•
Learn from mistakes
Passion
•
Infuse energy in everything that
you do
•
Walk that extra mile
•
Inspire others
•
Do your best in every situation
Integrity
•
Do the right thing with conviction &
without fear
•
Practice honesty, impartiality &
fairness at all times
•
Adhere to strong ethical and moral
standards
•
